GRVE GROOVE BOTANICALS INC.
Crude Petroleum & Natural Gas · OTC · SEC CIK 918573 · Fiscal year ends 03/31
Financial factors as of 2026-09-30 (2027Q2), TTM = sum of the last four quarters
Growth
TTM revenue YoY—
TTM net income YoY9.6%
TTM EPS YoY0.0%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—
Returns
ROE—
ROA-906.9%
ROIC (approx.)—
Asset turnover—
Leverage & solvency
Liabilities / assets8,725.0%
Debt / equity—
Current ratio0.01x
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.71x
Accruals ratio-263.4%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2027Q22026-09-30 | 2027Q12026-06-30 | 2026Q4*2026-03-31 | 2026Q32025-12-31 | 2026Q22025-09-30 | 2026Q12025-06-30 | 2025Q4*2025-03-31 | 2025Q32024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | — | — | — | — | — | — | — | — |
| SG&A expense | $8,092 | $18,719 | $22,251 | $16,041 | $18,018 | $18,965 | $20,900 | $17,255 |
| Operating income | -$32,762 | -$28,318 | -$35,497 | -$33,867 | -$32,383 | -$38,170 | -$31,430 | -$33,031 |
| Net income | -$31,562 | -$21,171 | -$35,497 | -$33,867 | -$32,383 | -$38,170 | -$31,430 | -$33,031 |
| EPS (basic) | — | — | — | — | — | 0.00 | — | 0.00 |
| EPS (diluted) | 0.00 | 0.00 | — | 0.00 | 0.00 | 0.00 | — | 0.00 |
| Weighted avg. shares (diluted) | — | — | — | — | — | 59.64M | — | 59.64M |
| Balance sheet | ||||||||
| Cash & equivalents | $1,866 | $1,494 | $1,502 | $1,494 | $1,492 | $2,737 | $2,042 | $1,251 |
| Current assets | $18,762 | $2,525 | $4,432 | $6,260 | $8,164 | $3,686 | $4,520 | $4,733 |
| Total assets | $18,762 | $2,525 | $4,432 | $6,260 | $8,164 | $3,686 | $4,520 | $4,733 |
| Current liabilities | $1.64M | $1.55M | $1.47M | $1.38M | $1.30M | $1.21M | $1.11M | $1.03M |
| Total liabilities | $1.64M | $1.55M | $1.47M | $1.38M | $1.30M | $1.21M | $1.11M | $1.03M |
| Shareholders' equity | -$1.62M | -$1.54M | -$1.47M | -$1.38M | -$1.29M | -$1.20M | -$1.11M | -$1.02M |
| Shares outstanding | 59.64M | 59.64M | 59.64M | 59.64M | 59.64M | 59.64M | 59.64M | 59.64M |
| Cash flow statement | ||||||||
| Operating cash flow | -$36,449 | -$14,187 | -$15,993 | -$20,001 | -$35,888 | -$19,786 | -$18,093 | -$25,861 |
| Investing cash flow | $0 | $0 | — | — | $0 | $0 | — | — |
| Financing cash flow | $36,821 | $14,179 | $16,001 | $20,003 | $34,643 | $20,481 | $18,884 | $20,979 |
Free plan shows the latest 8 periods; Pro shows all 49 🔒
· This company does not report gross profit in XBRL.
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.